Clinical Trial Update: Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating denosumab plus enzalutamide with or without abiraterone and prednisone in men with castration-resistant prostate cancer with bone metas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone (abiraterone)
• Denosumab (denosumab)
• Enzalutamide (enzalutamide)
• PREDNISONE (Prednisone)

Snippet

Sponsor: University of Hawaii | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2019-10-02